Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer

View Full Size 

Download

• Full Size JPEG, 2400x800, 604.4 KB
• Small JPEG, 480x160, 47.2 KB
• Preview JPEG, 144x48, 10.6 KB
• Thumbnail JPEG, 120x40, 8.8 KB